How are Government Initiatives Driving Aortic Valve Market?

Biological Aortic
Valves
Conducive for
Elderly
© Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
1

Factors such as increasing prevalence of valvular diseases and rising number of
initiatives for imparting awareness regarding valve replacement are expected to
supplement the aortic valve market growth at a CAGR of 13.2% during the
forecast period (2020–2030). At this rate, the market’s value will increase from
$7,568.3 billion in 2019 to $29,146.9 million by 2030.
Currently, the market is witnessing the trend of product launches. Manufacturing
companies are continuously focusing on developing new and improved products
to meet the spurring demand for aortic valves, across the world.
Receive Sample Pages of this Report:
https://www.psmarketresearch.com/market-analysis/aortic-valvemarket/report-sample
Aortic regurgitation and aortic stenosis are the most common valvular diseases.
Rheumatic heart disease (RHD) is the most common cause of aortic
regurgitation. According to the World Health Organization (WHO), nearly 33
million people around the globe are affected by RHD that accounts for around
2% of the population suffering from cardiovascular diseases (CVDs). These
conditions mostly affect the old people. Thus, booming geriatric population will
fuel the consumption of aortic valves in the coming years, which, in turn, will
drive the market growth.
Another key factor driving the aortic valve market is the growing support from
governments, worldwide. Government organizations are taking multiple
initiatives to impart knowledge regarding aortic valve replacement procedures.
For instance, the European Association of Percutaneous Cardiovascular
Interventions (EAPCI) launched Valve for Life initiative in Europe, in 2015. It
aims to improve the access to transcatheter valve procedures, enhance the
educational standards for healthcare professionals, raise awareness regarding
valvular diseases, decrease obstacles for therapy implementation, and end age
and gender discrimination in access to medical care, in the region.
Aortic valves are available as mechanical and tissue/biological valves. With
constant developments in technology and rapid demand for valves from the
ageing population, medical professionals are primarily opting for biological or
tissue aortic valves. These valves are implanted in the human body either
through open surgery or minimally invasive surgery (MIS). The surgeons are
preferring MIS implantation procedure, as it causes lesser trauma to the patients
and stimulates the recovery process, in comparison to open-heart surgeries.
These products and procedures are used in several healthcare facilities. Thus,
the end-user segment of the aortic valve market is bifurcated into hospitals and
ambulatory surgery centers (ASCs). Between the two, the hospitals category will
exhibit the fastest growth in the forecast period. This growth can be attributed to
© Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
2

the fact that hospitals are the most advanced facilities and offer optimal patient
care. Moreover, surging healthcare spending and an improving healthcare
reimbursement structure will propel the growth of the market in this category in
the coming years.
According to P&S Intelligence, Europe generated the maximum demand for
aortic valves in 2019 and it will retain its dominance in future, due to the
existence of an advanced healthcare system, growing elderly population, and
increasing incidence of chronic and lifestyle-associated diseases. Furthermore,
the European market is expected to witness the fastest growth during the
forecast period. This can be due to the rising cases of aortic stenosis in western
European nations. Doctors generally recommend transcatheter aortic valve
replacement (TAVR) and surgical valve replacement treatments for aortic
stenosis.
Thus, intensifying awareness among people and healthcare professionals
regarding aortic valves and replacement procedures will fuel the adoption of
these valves in the future.
The research offers market size of the breast biopsy devices for the period 2013–2023.
Market Segmentation by Product
• Guidance Systems
• Biopsy Needles/Guns
• Biopsy Tables
• Biopsy Wires
• Others
Market Segmentation by Procedure Type
• Vacuum-Assisted Biopsy
• Core Needle Biopsy
• Fine Needle Aspiration Biopsy
• Surgical Biopsy
Market Segmentation by Imaging Modality
• Mammography Guided Stereotactic Biopsy
• Ultrasound Guided Biopsy
• Magnetic Resonance Imaging (MRI) Guided Biopsy
• Computed Tomography (CT) Guided Biopsy
• Others
Market Segmentation by Geography
• North America Breast Biopsy Devices Market
o By Product
© Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
3

o By Procedure Type
o By Imaging Modality
o By Country – U.S. and Canada
• Europe Breast Biopsy Devices Market
o By Product
o By Procedure Type
o By Imaging Modality
o By Country – Germany, France, U.K., Italy, Spain, and Rest of Europe
• Asia-Pacific (APAC) Breast Biopsy Devices Market
o By Product
o By Procedure Type
o By Imaging Modality
o By Country – Japan, China, India, Australia and Rest of APAC
• Rest of the World (RoW) Breast Biopsy Devices Market
o By Product
o By Procedure Type
o By Imaging Modality
o By Country – Brazil, Mexico and Rest of RoW
© Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
4

Disclaimer:
P&S Intelligence always keeps its customers’ interests at the core while carrying out research
activities. P&S Intelligence ensures the reliability and accuracy of information and data provided
in its market research publications. However, the information in publications is subject to
fluctuations, as it is based on primary interviews of officials from various companies or
organizations. P&S Intelligence is not responsible for any incorrect data provided by the key
industry players of the concerned domain. The information or analysis in P&S Intelligence
publications represents opinions based on research and should not be interpreted as statements
of fact. Information in this report was believed to be correct at the time of publication, but
cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor
depicted in its research publications.
All intellectual properties, including trademarks and copyrights, belong to their respective
owners and may be protected by copyright. Under no circumstance can these be reproduced
in any form without prior written agreement of their owners.
An order for market research report is intended for internal use of the company only and not for
disclosure to third parties or any other publication in general. No service, report, or part thereof
provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed,
circulated, or sublicensed in any medium or form now realized or hereafter become realized,
including but not limited to, all forms of optical-based media, magnetic, electronic, or digital,
without a written permission from Prescient & Strategic Intelligence Pvt. Ltd.
Kindly write to: enquiry@psmarketresearch.com
B-13, Sector – 2, Noida, U.P. – 201301, INDIA
Contact No: +91 120 4541 337
US/Canada Toll-Free: 1-888-778-7886
© Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved
5